Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From COVID-19

February 2024 in “ PubMed ”

Ali Asilian, Fariba Iraji, Sayed Mohsen Hosseini, Parastoo Dehkordi

TLDR More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity

8 citations, May 2022 in “Journal of medicine and life”

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations, December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization

7 citations, December 2021 in “Journal of The American Academy of Dermatology”

COVID-19 can cause hair loss starting as early as 18 days after infection.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations, August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research Female Pattern Alopecia and Telogen Effluvium: Figuring Out Diffuse Alopecia

25 citations, June 2015 in “Seminars in Cutaneous Medicine and Surgery”

The article explains how to tell apart and treat two common causes of hair loss in women.